Der Autor untersucht und kommentiert die einzelnen forschungsbezogenen Regelungen des Zusatzprotokolls zum Ubereinkommen des Europarats uber Menschenrechte und Biomedizin. Bestehende nationale und internationale Bestimmungen werden vergleichend ebenso einbezogen wie allgemeine Rechtsgrundsatze, die die biomedizinische Forschung am Menschen in Deutschland derzeit pragen. Zugleich wird die Frage beantwortet, inwieweit das Zusatzprotokoll mit verfassungsrechtlichen Vorgaben vereinbar ist und eine Ubernahme in nationales Recht befurwortet werden kann."

When data from all aspects of our lives can be relevant to our health - from our habits at the grocery store and our Google searches to our FitBit data and our medical records - can we really differentiate between big data and health big data? Will health big data be used for good, such as to improve drug safety, or ill, as in insurance discrimination? Will it disrupt health care (and the health care system) as we know it? Will it be possible to protect our health privacy? What barriers will there be to collecting and utilizing health big data? What role should law play, and what ethical concerns may arise? This timely, groundbreaking volume explores these questions and more from a variety of perspectives, examining how law promotes or discourages the use of big data in the health care sphere, and also what we can learn from other sectors.

An account of the complex relationship between technology and romanticism that links nineteenth-century monsters, automata, and mesmerism with twenty-first-century technology's magic devices and romantic cyborgs. Romanticism and technology are widely assumed to be opposed to each other. Romanticism-understood as a reaction against rationalism and objectivity-is perhaps the last thing users and developers of information and communication technology (ICT) think about when they engage with computer programs and electronic devices. And yet, as Mark Coeckelbergh argues in this book, this way of thinking about technology is itself shaped by romanticism and obscures a better and deeper understanding of our relationship to technology. Coeckelbergh describes the complex relationship between technology and romanticism that links nineteenth-century monsters, automata, and mesmerism with twenty-first-century technology's magic devices and romantic cyborgs. Coeckelbergh argues that current uses of ICT can be interpreted as attempting a marriage of Enlightenment rationalism and romanticism. He describes the "romantic dialectic," when this new kind of material romanticism, particularly in the form of the cyborg as romantic figure, seems to turn into its opposite. He shows that both material romanticism and the objections to it are still part of modern thinking, and part of the romantic dialectic. Reflecting on what he calls "the end of the machine," Coeckelbergh argues that to achieve a more profound critique of contemporary technologies and culture, we need to explore not only different ways of thinking but also different technologies-and that to accomplish the former we require the latter.

As the demand for organs continues to outstrip availability and waiting lists surge, the pressure to make morally questionable, unethical decisions becomes more likely and trust in transplant medicine starts to erode. Medical ethics expert and former health professional, Trevor Stammers, analyses the complex ethical web that constitutes the worldwide exchange of organs and tissues. Key philosophical questions concerning existence, consciousness, the nature of death and the right to life connect organ donation and transplantation to real-life case studies exploring difficulties with the 'dead donor rule' for deceased donation, organ donation euthanasia, xenotransplantation and the creation of organoids and 'organs-on-chips', alongside examples of human trafficking and systematic state murder to provide organs. Controversial cases from Japan, Germany, USA and Singapore are examined alongside the Spanish, Welsh, and Chilean experience of deceased donation opt-out schemes to highlight the variety of threats and challenges to public trust in transplant medicine. Charting these examples provides valuable material for debates and discussions in the philosophy of medicine and medical ethics more generally. Stammers suggests viable alternatives to current ethical failings by focusing on the moral arguments that define public trust, moving the debate on transplant ethics in vital new directions.

Bioethics is the philosophical study of the ethical controversies brought about by advances in biology and medicine. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, philosophy, and theology. This book presents research in the expansive field of bioethics including biomedical ethics in obstetrics, ethical decision making in the health care system, the feasibility of using human oocytes for stem cell research, as well as mandatory circumcision in Sub-Saharan Africa to prevent HIV and AIDS and environmental ethics to preserve the world for future generations.

This book presents theoretical and applied issues including ethical theory, moral, social, political, and legal philosophy. Issues include: biology and medicine, business, education, environment, government, mass media, science, agriculture and food production, and religion.

This book provides an overview of the US laws that affect clinical practice for healthcare professionals with no legal background. Divided into thirteen sections, each chapter starts with a summary of the chapter's content and relevant legal concepts in bullet points before discussing the topics in detail. An application section is provided in many chapters to clarify essential issues by reflecting on clinically relevant case law or clinical vignette(s). Filling a crucial gap in the literature, this comprehensive guide gives healthcare professionals an understanding or a starting point to legal aspects of healthcare.

The boundaries of life now occupy a place of central concern among biological anthropologists. Because of the centrality of the modern biological definition of life to Euro-American medicine and anthropology, the definition of life itself and its contestation exemplify competing uses of knowledge. On the one hand, "life" and "death" may be redefined as partial or contingent ("brain death"), or reconstituted altogether ("virtual" or "artificial life"). On the other hand, the finality and "reality" of death resists such classifications. This volume reflects a growing international concern about issues such as organ transplantation, new reproductive and genetic technologies and embryo research, and the necessity of cross-cultural comparison. The political economy of body parts, organ and tissue "harvesting," bio-prospecting, and the patenting of life-forms are explored herein, as well as governance and regulation in cloning, organ transplantation, tissue engineering, and artificial life systems procedures.

While the Christian church has experienced extraordinary growth over the last century, Western culture has continued its seemingly inexorable drift into post-Christian forms. The contrast between our burgeoning churches and the scant impact that Christians have on public policy, the university, or the professions is distressing. And nowhere is this development more evident-and more consequential-than in the field of bioethics, where the dignity of human beings is constantly open to redefinition, and where much of our inheritance is coming under withering fire from those whose values are radically distinct from the Judeo-Christian tradition. This new volume takes seriously the Christian mandate to engage modern culture, giving specific attention to the urgent need for moral leadership as we encounter the difficult challenges posed by biotechnology. These insightful chapters by twenty leading activists, academics, and professionals discuss the contributions that a Christian perspective can and should make to the biomedical debate in today's most important forums-public policy and law, education, media, health care, and the church itself.

What should a vet do when a client can't pay for their animal's treatment? Or when asked their opinion on the killing of wildlife for disease control? Or when observing an animal welfare problem whilst off duty?Ethical problems are an everyday part of life for veterinarians but it can be difficult to combine personal values with professional conduct. Veterinary Ethics presents a range of ethical scenarios that veterinarians and other allied animal health professionals may face in practice. The scenarios discussed are not only exceptional cases with potentially significant consequences, but often less dramatic everyday situations.The responses to these ethical problems are from practising veterinarians and acknowledged world experts in animal welfare and ethics. The advice given is thorough and detailed, covering different eventualities, the ethical knots and dilemmas, the personal feelings of those involved as well as objective recommendations on ethical decision making and, where relevant, guidance from veterinary governing bodies and the law. The advice is framed in the form of veterinary life in the real world, not necessarily an ideal world.As well as practical guidance the book takes a step back and explores the different philosophical arguments and standpoints and the resultant solutions and problems of each approach, examining the background and relationship between different philosophical schools of thought, ethics and veterinary care. The book strives to present decision making in response to ethical problems as transparently as possible, employing a range of ethical frameworks.The book also challenges the reader about their own decision making in given situations, what factors to consider and how they would achieve certain outcomes.

A pithy work of philosophical anthropology that explores why humans find moral orders in natural orders. Why have human beings, in many different cultures and epochs, looked to nature as a source of norms for human behavior? From ancient India and ancient Greece, medieval France and Enlightenment America, up to the latest controversies over gay marriage and cloning, natural orders have been enlisted to illustrate and buttress moral orders. Revolutionaries and reactionaries alike have appealed to nature to shore up their causes. No amount of philosophical argument or political critique deters the persistent and pervasive temptation to conflate the "is" of natural orders with the "ought" of moral orders. In this short, pithy work of philosophical anthropology, Lorraine Daston asks why we continually seek moral orders in natural orders, despite so much good counsel to the contrary. She outlines three specific forms of natural order in the Western philosophical tradition-specific natures, local natures, and universal natural laws-and describes how each of these three natural orders has been used to define and oppose a distinctive form of the unnatural. She argues that each of these forms of the unnatural triggers equally distinctive emotions: horror, terror, and wonder. Daston proposes that human reason practiced in human bodies should command the attention of philosophers, who have traditionally yearned for a transcendent reason, valid for all species, all epochs, even all planets.

This collection of essays, commissioned by the President's Council on Bioethics, explores a fundamental concept crucial to today's discourse in law and ethics in general and in bioethics in particular. Since its formation in 2001, the council has frequently used the term "human dignity" in its discussions and reports. In this volume scholars from the fields of philosophy, medicine and medical ethics, law, political science, and public policy address the issue of what the concept of "human dignity" entails and its proper role in bioethical controversies. Human Dignity and Bioethics is an attempt to clarify a controversial concept, one that is a critical component in the decisions of policymakers. Contributors: Adam Schulman, F. Daniel Davis, Daniel C. Dennett, Robert P. Kraynak, Alfonso Gomez-Lobo, Patricia S. Churchland, Gilbert Meilaender, Holmes Rolston III, Charles Rubin, Nick Bostrom, Richard John Neuhaus, Peter Augustine Lawler, Diana Schaub, Leon R. Kass, Susan M. Shell, Martha Nussbaum, David Gelernter, Patrick Lee, Robert P. George, Paul Weithman, Daniel P. Sulmasy, O.F.M., Rebecca Dresser, and Edmund D. Pellegrino.

Genetics and its related technologies are revolutionising the world in which we live: The media is regularly dominated by the latest genetically modified (GM) food, human gene therapy or cancer chip technology; maverick scientists are in the process of cloning humans and the human genome sequence is available on the Internet. Fifty years ago we did not know what a gene was - today the awesome power of genetics is being released on an unsuspecting public, and with it a whole series of ethical dilemmas undreamth of even ten years ago. Does the question now become not 'can we?' but 'should we?'
By demystifying genetic engineering and exploring the basic biology underlying the living world, A Terrible Beauty is Born explains how clones and cloning technology are in many ways extensions of processes occurring constantly in nature. Used wisely these processes have the potential to bring enormous benefits; abused, they carry with them potential dangers which we ignore at our peril.

The Future of the Disabled in Liberal Society questions developments in human genetic research from the perspective of persons with mental disabilities and their families. Hans S. Reinders argues that when we use terms such as “disease” and “defect” to describe conditions that genetic engineering might well eliminate, we may also be assuming that disabled lives are deplorable and horrific. Reinders points out that the possibility of preventing disabled lives is at odds with our commitment to the full inclusion of disabled citizens in society. The tension between these different perspectives is of concern to all of us as genetic testing procedures proliferate. Reinders warns that preventative uses of human genetics might even become a threat to the social security and welfare benefits that help support disabled persons and their families. Reinders also argues that this conflict cannot be resolved or controlled on the level of public morality. Because a liberal society makes a commitment to individual freedom and choice, its members can consider the diagnostic and therapeutic uses of human genetics as options available to individual citizens. A liberal society will defend reproductive freedom as a matter of principle. Citizens may select their offspring in accord with their own personal values. Reinders concludes that the future of the mentally disabled in liberal society will depend on the strength of our moral convictions about the value of human life, rather than on the protective force of liberal morality. One of the most important aspects of this book is Reinder’s attention to parents who have come to see the task of raising a disabled child as an enriching experience. These are people who change their conceptions of success and control and, therefore, their conceptions of themselves. They come to value their disabled children for what they have to give. Even though disabled children and disabled adults present parents and society with real challenges, the rewards are just as real. This powerful critique of contemporary bioethics is sure to become required reading for those interested in human development, special education, ethics, philosophy, and theology.

Talk of genetically engineered organisms (GEOs) has moved from the hushed corridors of life science corporations to the front pages of the world's major newspapers. As Europeans began rejecting genetically engineered foods in the marketplace, the StarLink corn incident exploded in the United States and farmers set fire to genetically modified crops in India. Citizens and consumers have become increasingly aware of and troubled by the issues surrounding these new technologies. Considering cases from agriculture, food, forestry, and pharmaceuticals, this book examines some of the most pressing questions raised by genetic engineering. What determines whether GEOs enter the food supply, and how are such decisions being made? How is the biotechnology industry using its power to reshape food, fiber, and pharmaceutical production, and how are citizen-activists challenging these initiatives? And what are the social and political consequences of global differences over GEOs?

Technology evolves at a dazzling speed, and nowhere more so than in the field of genetic engineering, where the possibility of directly changing the genes of one's children is quickly becoming a reality. The public is rightly concerned, but interestingly, they have not had much to say about the implications of recent advancements in human genetics.
"Playing God?" asks why and explores the social forces that have led to the thinning out of public debate over human genetic engineering. John H. Evans contends that the problem lies in the structure of the debate itself. Disputes over human genetic engineering concern the means for achieving assumed ends, rather than being a healthy discussion about the ends themselves. According to Evans, this change in focus occurred as the jurisdiction over the debate shifted from scientists to bioethicists, a change which itself was caused by the rise of the bureaucratic state as the authority in such matters. The implications of this timely study are twofold. Evans not only explores how decisions about the ethics of human genetic engineering are made, but also shows how the structure of the debate has led to the technological choices we now face.

A new idea of the future emerged in eighteenth-century France. With the development of modern biological, economic, and social engineering, the future transformed from being predetermined and beyond significant human intervention into something that could be dramatically affected through actions in the present. The Time of Enlightenment argues that specific mechanisms for constructing the future first arose through the development of practices and instruments aimed at countering degeneration. In their attempts to regenerate a healthy natural state, Enlightenment philosophes created the means to exceed previously recognized limits and build a future that was not merely a recuperation of the past, but fundamentally different from it. A theoretically inflected work combining intellectual history and the history of science, this book will appeal to anyone interested in European history and the history of science, as well as the history of France, the Enlightenment, and the French Revolution.

Neglected diseases are severe conditions that mainly affect the world's poorest people. Those suffering from neglected diseases are mostly suffering from tropical infections that have failed to receive priority in pharmaceutical research and development programs, as well as in public health policies aimed at improving availability and access to preventive, diagnostic and curative medicine. The World Health Organization has issued a number of documents directing attention to the plight affecting one third of the world's population, assisted by active support from private organizations, notably the Bill and Melissa Gates Foundation, but the overall situation remains dismal. In the wake of major socioeconomic processes including globalization, steadily growing economic disparity, healthcare inequality, the instability created by rogue states and terrorism, as well as massive migration, and epidemic outbreaks, the features of neglected diseases have been changing. Neglected populations affected by tropical diseases are suffering increasingly from non-infectious degenerative conditions and disabilities due to untreated chronic maladies. Pockets of poverty and neglect can also be detected in high-income countries, contributing to the emergence of new diseases and the reemergence of infections believed to be disappearing such as tuberculosis and the measles. Included in the issues of neglect are rare diseases, mostly of genetic origin, affecting a small number of patients that suffer from multiple life-shortening functional impairment and organ defects. Effective medicines are extremely expensive, allegedly because research and development of appropriate drugs is resources and time consuming, requiring exorbitant prices to recoup investment from a small number of consumers. Bioethics has been tardy in addressing the suffering and destitution of neglected and rare diseases. Convinced that permanently repeated denunciations blunt the sensitivity towards suffering, whereas statistics are bloodless and unable to elicit commitment, this book attempts to explore a different strategy. In an upstream approach, bioethics needs to engage in ethnographic fieldwork that confronts and shares the context in which people suffer, vividly presenting what epidemiological research has blunted into statistical data. Additionally, a downstream approach is suggested, requiring bioethics to vigorously and openly denounce unethical biomedical and pharmaceutical research, misdeeds in registration and marketing of drugs, and misalignment of policies with the unmet healthcare needs of the destitute. More than being critical observers, bioethicists ought to shed lurking conflicts of interests and seek active participation in planning research and public healthcare practices aimed at improving the lives of medically neglected populations.

Written with passion for anyone interested in seeing an end to the illegal trade in elephant ivory and rhino horn, this book shows how, by working together, people all over the world who care about these animals are gradually bringing about change for the better. It takes an overview of how the current situation came to pass by exploring poaching and its devastating consequences and the pivotal role of organized crime. The discussion of how matters are starting to improve covers the investigation and monitoring of ivory markets, sustainable uses and the key role of local communities.Enforcement of the law is vital in this story. Enter the enforcers, the technology they use to defeat the poachers and the evidence they require to prosecute offenders. Cases, some deeply shocking, are included, as well as a number of fascinating case studies, while the exploits of organized crime gangs make lively, as well as disturbing reading. Throughout the message is clear. We can and must save these animals from extinction.

This volume links three different theoretical approaches that have a common focus on the relationship between biopolitics and bioethics. This collection of papers can be categorized into different domains that are representative of the contemporary usage of biopolitics as a concept. On the one hand, several chapters develop a clear and up-to-date understanding of the primary sources of the concept and related theories of Agamben, Negri or Foucault and approach the question of relevance within the field of bioethics. Another group of papers apply the philosophical concepts and theories of biopolitics (biopower, Homo Sacer, biocitizenship) on very specific currently debated bioethical issues. Some scholars rely on the more mundane understanding of (bio)politics and investigate how its relationship with bioethics could be philosophically conceptualized. Additionally, this work also contains papers that follow a more legally oriented analysis on the effects of contemporary biopolitics on human rights and European law. The authors are philosophers, legal scholars or bioethicists. The major strength of this volume is to provide the reader with major insights and orientation in these different contemporary usages of the concept and theories of biopolitics, within the context of its various ethically relevant applications.

Focusing on the period between the 1970s and the present, Life as Surplus is a pointed and important study of the relationship between politics, economics, science, and cultural values in the United States today. Melinda Cooper demonstrates that the history of biotechnology cannot be understood without taking into account the simultaneous rise of neoliberalism as a political force and an economic policy. From the development of recombinant DNA technology in the 1970s to the second Bush administration's policies on stem cell research, Cooper connects the utopian polemic of free-market capitalism with growing internal contradictions of the commercialized life sciences. The biotech revolution relocated economic production at the genetic, microbial, and cellular level. Taking as her point of departure the assumption that life has been drawn into the circuits of value creation, Cooper underscores the relations between scientific, economic, political, and social practices. In penetrating analyses of Reagan-era science policy, the militarization of the life sciences, HIV politics, pharmaceutical imperialism, tissue engineering, stem cell science, and the pro-life movement, the author examines the speculative impulses that have animated the growth of the bioeconomy. At the very core of the new post-industrial economy is the transformation of biological life into surplus value. Life as Surplus offers a clear assessment of both the transformative, therapeutic dimensions of the contemporary life sciences and the violence, obligation, and debt servitude crystallizing around the emerging bioeconomy.

Quality, as exemplified by Quality-of-life (QoL) assessment, is frequently discussed among health care professionals and often invoked as a goal for improvement, but somehow rarely defined, even as it is regularly assessed. It is understood that some medical patients have a better QoL than others, but should the QoL achieved be compared to an ideal state, or is it too personal and subjective to gauge? Can a better understanding of the concept help health care systems deliver services more effectively? Is QoL worth measuring at all? Integrating concepts from psychology, philosophy, neurocognition, and linguistics, this book attempts to answer these complex questions. It also breaks down the cognitive-linguistic components that comprise the judgment of quality, including description, evaluation, and valuations, and applies them to issues specific to individuals with chronic medical illness. In this context, quality/QoL assessment becomes an essential contributor to ethical practice, a critical step towards improving the nature of social interactions. The author considers linear, non-linear, and complexity-based models in analyzing key methodology and content issues in health-related QoL assessment. This book is certain to stimulate debate in the research and scientific communities. Its forward-looking perspective takes great strides toward promoting a common cognitive-linguistic model of how the judgment of quality occurs, thereby contributing important conceptual and empirical tools to its varied applications, including QoL assessment.

Contemporary Debates in Bioethics features a timely collection of highly readable, debate-style arguments contributed by many of today s top bioethics scholars, focusing on core bioethical concerns of the twenty-first century. * Written in an engaging, debate-style format for accessibility to non-specialists * Features general introductions to each topic that precede scholarly debates * Presents the latest, cutting-edge thoughts on relevant bioethics ideas, arguments, and debates

Biotechnology crop production area increased from 1.7 million hectares to 148 million hectares worldwide between 1996 to 2010. While genetically modified food is a contentious issue, the debates are usually limited to health and environmental concerns, ignoring the broader questions of social control that arise when food production methods become corporate-owned intellectual property. Drawing on legal documents and dozens of interviews with farmers and other stakeholders, Corporate Crops covers four case studies based around litigation between biotechnology corporations and farmers. Pechlaner investigates the extent to which the proprietary aspects of biotechnologies-from patents on seeds to a plethora of new rules and contractual obligations associated with the technologies-are reorganizing crop production. The lawsuits include patent infringement litigation launched by Monsanto against a Saskatchewan canola farmer who, in turn, claimed his crops had been involuntarily contaminated by the company's GM technology; a class action application by two Saskatchewan organic canola farmers launched against Monsanto and Aventis (later Bayer) for the loss of their organic market due to contamination with GMOs; and two cases in Mississippi in which Monsanto sued farmers for saving seeds containing its patented GM technology. Pechlaner argues that well-funded corporate lawyers have a decided advantage over independent farmers in the courts and in creating new forms of power and control in agricultural production. Corporate Crops demonstrates the effects of this intersection between the courts and the fields where profits, not just a food supply, are reaped.